铁调素和IL-6在非酒精性脂肪性肝病大鼠模型肝脏炎症进程中的表达水平及相关性分析

赵睿; 李娟; 王亮; 孔银; 丁洁; 王娟霞; 李光明; 张岭漪

doi:10.3969/j.issn.1001-5256.2017.09.030

铁调素和IL-6在非酒精性脂肪性肝病大鼠模型肝脏炎症进程中的表达水平及相关性分析

DOI: 10.3969/j.issn.1001-5256.2017.09.030

兰州大学第二医院肝病科

基金项目:

2014年甘肃省自然科学基金项目(145RJZA147)；中央高校基本科研业务费专项资金(223000-861240)；

详细信息

中图分类号: R-332;R575.5
计量
- 文章访问数: 2040
- HTML全文浏览量: 58
- PDF下载量: 440
- 被引次数: 0
出版历程
- 收稿日期: 2017-06-10
- 出版日期: 2017-09-20

Expression of hepcidin and interleukin-6 and their correlation in liver inflammation process in a rat model of nonalcoholic fatty liver disease

Department of Hepatology, Lanzhou University Second Hospital

Research funding:

摘要

摘要:
目的利用非酒精性脂肪性肝病（NAFLD）大鼠模型观察铁调素（Hepc）、IL-6在肝脏炎症进程中表达水平的变化。方法NAFLD肝组织标本均来自本课题组前期利用高脂乳剂灌胃法成功构建的大鼠NAFLD模型（M组）及同期生理盐水灌胃替代构建的正常大鼠对照组（C组）。Hepc、IL-6单克隆抗体应用免疫组织化学法分别检测4、8、12周M组(M4、M8、M12)和12周C组大鼠肝组织中Hepc、IL-6的表达水平,同期评估各组肝脂肪炎症程度积分。检测2组大鼠肝组织Hepc和IL-6的表达水平,并计算肝组织NAS积分。多组间比较采用单因素方差分析,组间进一步两两比较采用LSD-t相关法。相关性分析均采用Pearson相关法。结果随试验周期延长,Hepc和IL-6在M4组、M8组、M12组表达水平呈逐渐升高的趋势,且与C12组相比差异均有统计学意义（Hepc:0.372±0.216、1.213±0.193、2.390±0.192 vs 0.166±...
- 脂肪肝 /
- 铁调节蛋白质类 /
- 白细胞介素6
Abstract:
Objective To investigate the changes in the expression of hepcidin ( Hepc) and interleukin-6 ( IL-6) in liver inflammation process in a rat model of nonalcoholic fatty liver disease ( NAFLD) . Methods The rats were given high-fat emulsion by gavage to establish the model of NAFLD ( group M) and normal rats were given normal saline by gavage as controls ( group C) . Liver tissue samples were collected from these rats, and immunohistochemistry was used to measure the expression of Hepc and IL-6 in liver tissue in group M at 4, 8, and 12weeks ( M4, M8, and M12groups) and in group C at 12 weeks ( C12group) . The NAFLD activity score ( NAS) was assessed for both groups.The expression of Hepc and IL-6 in liver tissue was measured, and NAS was calculated. A one-way analysis of variance was used for comparison between multiple groups, and the least significant difference t-test was used for comparison between two groups. Pearson correlation analysis was also performed. Results Over the course of treatment, the M4, M8, and M12 groups had gradual increases in the expression of Hepc and IL-6, and there were significant differences between these groups and the C12group ( Hepc: 0. 372 ± 0. 216/1. 213 ± 0. 193/2. 390± 0. 192 vs 0. 166 ± 0. 192, all P < 0. 05; IL-6: 0. 499 ± 0. 218/1. 290 ± 0. 210/2. 644 ± 0. 441 vs 0. 240 ± 0. 109, all P < 0. 05) . In group M, the expression of Hepc was positively correlated with that of IL-6 ( r = 0. 944, P < 0. 05) , and the expression Hepc and IL-6 was positively correlated with NAS ( r = 0. 927 and 0. 907, both P < 0. 001) . Conclusion Based on the results of this preliminary study, liver inflammation process in NAFLD can upregulate the expression of Hepc and IL-6 in liver tissue, and Hepc is significantly correlated with the inflammatory factor IL-6. Further studies are needed to investigate the roles of Hepc and IL-6 in predicting the progression of NAFLD.
- fater liver /
- iron-regulatory proteins /
- interleukin-6

HTML全文

参考文献(13)

[1]DATZ C, FELDER TK, NIEDERSEER D, et al.Iron homeostasis in the metabolic syndrome[J].Eur J Clin Investig, 2013, 43 (2) :215-224.

[2]DONGIOVANNI P, FRACANZANI AL, FARGION S, et.al.Iron in fatty liver and in the metabolic syndrome:a promising therapeutic target[J].Hepatol, 2011, 55 (2) :920-932.

[3]ANTONELLO P.Hepcidin in human iron disorders:therapeutic implications[J].Hepatology, 2011, 54 (2) :173-181.

[4] WANG J, PANTOPOULOS K.Regulation of cellular iron metabolism[J].Biochem, 2011, 434 (2) :365-381.

[5]DING J, WANG L, LI J, et al.Reliability of metabolic and pathologic parameters in the high fat diet-induced nonalcoholic fatty liver disease rat model established by gastric perfusion[J].J Clin Hepatol, 2012, 7 (2) :531-534. (in Chinese) 丁洁, 王亮, 李娟, 等.高脂乳剂灌胃构建大鼠非酒精性脂肪肝病模型可靠性的再研究[J].临床肝胆病杂志, 2012, 7 (2) :531-534.

[6]FU Q, LI P, XIONG F, et al.Dicussion of enhancement of normal SP immunohistochemical staining[J].J Hubei Univ Chin Med, 2013, 15 (5) :24-26. (in Chinese) 富青, 李萍, 熊凡, 等.改良常规SP免疫组化染色法的探讨[J].湖北中医药大学学报, 2013, 15 (5) :24-26.

[7] Group of Fatty Liver and Alcoholic Liver Diseases, Society of Hepatology, Chinese Medical Association.Guidelines for management of non-alcoholic fatty liver disease[J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病学分会.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志, 2010, 26 (2) :120-124.

[8]AIGNER E, WEISS G, DATZ C.Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver[J].World J Hepatol, 2015, 7 (2) :177-188.

[9]WANG FG, LIANG WF, XI JJ.Establishment and applications of non-alcoholic steatohepatitis animal models[J].Chin J Clin Pharmacol Ther, 2015, 20 (7) :835-840. (in Chinese) 王福根, 梁伟峰, 席建军, 等.非酒精性脂肪性肝炎动物模型的建立与应用[J].中国临床药理学与治疗学, 2015, 20 (7) :835-840.

[10] BOQA S, ALKIN H, ALKIN C, et.al.The relationship of serum hemojuvelin and hepcidin levels with iron overload in nonalcoholic fatty liver disease[J].Gastrointestin Liver Dis, 2015, 24 (3) :293-300.

[11] RAVASI G, PELUCCHI S, TROMBINI P, et al.Hepcidin expression in iron overload diseases in variably moclulated by circulating[J].PLos One, 2012, 7 (5) :e36425.

[12] GANZ T.Hepcidin and iron regulation, 10 years later[J].Blood, 2011, 117 (17) :4425-4433.

[13] GANZ T.Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation[J].Blood, 2003, 102 (3) :783-788.

施引文献

资源附件(0)

访问统计